DNA topoisomerase II alpha: a favorable prognostic factor in colorectal caner
作者： Xian Hua Gao , Zhi Qi Yu , Chang Zhang , Chen Guang Bai , Jian Ming Zheng
DOI: 10.1007/S00384-011-1346-X
关键词:
摘要: Purpose There is a lack of study concerning expression Topoisomerase IIα (Topo IIα) and long-term results in colorectal cancer patients. We aimed to investigate the relationship between Topo clinicopathological parameters including overall survival cancer.
springer.com
sci-hub.se 参考文章(21)
Constantinos P. Zambirinis, Paraskevas Stamopoulos, Sotirios-George Panoussopoulos, Konstantinos Bramis, George E. Theodoropoulos, John Bramis, Emmanouil Leandros, Joanna G. Papailiou, Eleni Karafoka, P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up. Anticancer Research. ,vol. 29, pp. 785- 791 ,(2009)
Alan Coss, Miriam Tosetto, Edward J. Fox, Beata Sapetto-Rebow, Sheeona Gorman, Breandán N. Kennedy, Andrew T. Lloyd, John M. Hyland, Diarmuid P. O’Donoghue, Kieran Sheahan, Dermot T. Leahy, Hugh E. Mulcahy, Jacintha N. O’Sullivan, Increased topoisomerase IIα expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis Cancer Letters. ,vol. 276, pp. 228- 238 ,(2009) , 10.1016/J.CANLET.2008.11.018
Hilal Hafian, Lydie Venteo, Alyona Sukhanova, Igor Nabiev, Benoı̂t Lefevre, Michel Pluot, Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase IIα, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas ☆ Human Pathology. ,vol. 35, pp. 745- 751 ,(2004) , 10.1016/J.HUMPATH.2004.02.004
Asif I Haq, Jenifer Schneeweiss, Vinay Kalsi, Manit Arya, The Dukes staging system: a cornerstone in the clinical management of colorectal cancer Lancet Oncology. ,vol. 10, pp. 1128- ,(2009) , 10.1016/S1470-2045(09)70157-3
Jena M Giltnane, David L Rimm, Technology Insight: identification of biomarkers with tissue microarray technology Nature Reviews Clinical Oncology. ,vol. 1, pp. 104- 111 ,(2004) , 10.1038/NCPONC0046
S Retsas, K Henry, M.Q Mohammed, K MacRae, Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC): validation in a cohort of 1284 patients European Journal of Cancer. ,vol. 38, pp. 511- 516 ,(2002) , 10.1016/S0959-8049(01)00394-X
I. A. M. Ahmed, S. B. Kelly, J. J. Anderson, B. Angus, C. Challen, J. Lunec, The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer. Colorectal Disease. ,vol. 10, pp. 344- 351 ,(2008) , 10.1111/J.1463-1318.2007.01317.X
Deepa Saxena, Gary K. Yiu, Xiaoyan Ni, Kuan-Chun Huang, Roberto Mantovani, Alain G. Jacquemin-Sablon, Shu-Wing Ng, Characterization of promoter elements involved in the down-regulation of topoisomerase IIα expression in a drug-resistant cell line Gene. ,vol. 342, pp. 145- 155 ,(2004) , 10.1016/J.GENE.2004.07.033
Kenneth SH Chok, Wai Lun Law, None, Prognostic Factors Affecting Survival and Recurrence of Patients with pT1 and pT2 Colorectal Cancer World Journal of Surgery. ,vol. 31, pp. 1485- 1490 ,(2007) , 10.1007/S00268-007-9089-0
Florence Le Pessot, Pierre Michel, Marianne Paresy, Françoise Lemoine, Marie-France Hellot, Bernard Paillot, Michel Scotte, Christophe Peillon, Hemet Jacques, Cell proliferation in colorectal adenocarcinomas: comparison between Ki-67 immunostaining and bromodeoxyuridine uptake detected by immunohistochemistry and flow cytometry. Pathology Research and Practice. ,vol. 197, pp. 411- 418 ,(2001) , 10.1078/0344-0338-00054